Expression of prohibitins on the surface of activated T cells. by unknown
 1 
Expression of prohibitins on the surface of activated T cells. 
Hajime Yurugia, Shuhei Tanidaa, Akiko Ishidaa, Kaoru Akitaa, Munetoyo Todaa, Mizue Inoueb 
and Hiroshi Nakadaa* 
 
aDepartment of Molecular Bioscience, Faculty of Life Science, bAvian Influenza Research 
Center, Kyoto Sangyo University, Kamigamo-Motoyama, kitaku, Kyoto 603-8555, Japan 
*Corresponding author. Tel & Fax: +81-75-705-1888 
E-mail: hnakada@cc.kyoto-su.ac.jp (H Nakada) 
 2 
Abstract 
Prohibitins (prohibitin-1 and -2) comprise a family of highly conserved proteins that are mainly 
localized to mitochondria. Recent studies showed that prohibitins are up-regulated upon T cell 
activation and play an essential role in maintaining mitochondrial homeostasis. In the present 
study, we found that a considerable proportion of prohibitin-1 and -2 induced in response to T 
cell activation was expressed on the surface of activated T cells. When mouse and human T 
cells were stimulated with PMA and ionomycin, prohibitins expressed on the cell surface were 
increased significantly, peaking at 48 h after stimulation. Stimulation of mouse T cells with 
anti-CD3 and anti-CD28 antibodies also remarkably induced the cell surface expression of 
prohibitins. Their expression on the cell surface was also detected in T cell leukemia cells such 
as Jurkat cells. In Jurkat cells, prohibitin-1 and -2 were co-localized with CD3 on the cell 
surface, and anti-CD3 antibody-induced signaling, the MAP kinase cascade, was inhibited on 
treatment with protein A magnetic beads co-conjugated with anti-CD3 antibody and 
anti-prohibitin-1 or anti-prohibitin-2 antibody. These results suggest that prohibitins expressed 
on the surface of activated T cells are involved in the T cell receptor-mediated signaling 
cascade.  
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Introduction 
Although prohibitins (prohibitin-1 and -2) are primarily localized to mitochondria, recent 
studies showed that they are present in multiple cellular compartments and possess diverse 
functions [1-3]. Prohibitin-1 and -2 have molecular masses of approximately 30 kDa and 37 
kDa, respectively, and form a high molecular mass complex. In mitochondria, they are located 
in the inner membrane, where they stabilize mitochondrial respiratory enzymes [4, 5]. Nuclear 
prohibitins play a role as transcriptional regulators in combination with some transcriptional 
factors such as p53 and E2F1, which control proliferation and apoptosis, respectively [6, 7]. The 
nuclear localization of prohibitins has often been described in breast and prostate cancer cell 
lines [8, 9]. It has also been reported that prohibitin-2 interacts and inhibits the transcriptional 
activity of estrogen receptor [10]. Prohibitins were originally identified as B cell 
receptor-associated proteins, and revealed to be relevant to modulate signaling in B cells [11]. 
Prohibitins have also been shown to regulate the activation of c-Raf in epithelial cancer cells 
[12]. Recently, Ross et al. reported that prohibitins are markedly induced upon T cell activation 
and are responsible for maintaining mitochondrial integrity [13]. Furthermore, genetic deletion 
of prohibitin-1 or -2 in mice is lethal before embryonic day 9.0, indicating that prohibitins play 
a pivotal role at an early embryonic stage [14, 15]. In the present study, we found that 
expression of prohibitins on the cell surface was induced remarkably upon T cell activation. 
Their cell surface expression was also observed in T cell leukemia cells. Co-localization of 
prohibitins with CD3, and the inhibitory effects of anti-prohibitin-1 and anti-prohibitin-2 
antibodies on anti-CD3 antibody-induced signaling suggest that prohibitin-1 and prohibitin-2 on 
the cell surface play an important role in the regulation of T cell signaling.  
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Materials and methods 
Animals and cells 
Balb/c mice (5-7w, female) were purchased from SHIMIZU Laboratory Supplies Co., Ltd. and 
kept under SPF conditions. T cell leukemia cell lines, Molt-3, Molt-4, and Jurkat cells, were 
obtained from ATCC. Primary T cells and T cell leukemia cells were cultured in RPMI-1640 
supplemented with 10% heat inactivated fetal calf serum (Cell Culture Bioscience), 2 mM 
L-glutamine, 50 IU/ml penicillin, and 50 µg/ml streptomycin. 
 
Preparation and activation of T cells 
Mouse T cells were obtained from mouse spleens using a Pan T Cell Isolation Kit II (Miltenyi 
Biotec). Mouse CD4+ and CD8+ T cells were separated using anti-CD4 antibody- and anti-CD8 
antibody-conjugated microbeads (Miltenyi Biotec), respectively. Human T cells were prepared 
from peripheral blood mononuclear cells (PBMCs) of healthy donors using anti-CD3 
antibody-conjugated microbeads (Miltenyi Biotec). Mouse and human T cells (1.5 x 106 cells) 
were stimulated with 100 nM phorbol 12-myristate 13-acetate (PMA) and 500 ng/ml ionomycin. 
Mouse T cells were also stimulated with anti-mouse CD3 antibody (BioLegend, clone 
145-2C11), which was coated on a culture plate (6 well, BD), in the presence of 5 µg/ml 
anti-mouse CD28 antibody (BioLegend, clone 37.51) and 100 U/ml mouse IL-2 (CST).  
 
Analysis of induced prohibitins 
Some activated and non-activated T cells were solubilized with lysis buffer (50 mM Tris-HCl, 
pH7.5, 150 mM NaCl, 1% Triton-X100, 2mM EDTA, and 1% protease inhibitor cocktail 
(nacalai tesque)) at the indicated times after stimulation. Each lysate was subjected to 
SDS-PAGE, followed by Western blotting. Other activated and non-activated T cells were 
treated with EZ-Link sulfo-NHS biotin (Thermo Scientific) according to the manufacturer’s 
instructions. After washing with PBS containing 0.1 M glycine, the cells were solubilized as 
described above. Streptavidin-Sepharose (GE Healthcare) was added to each cell lysate 
containing the same amount of proteins, followed by stirring at 4! for 1 h. After washing with 
lysis buffer, proteins precipitated with the resin were dissolved in SDS-PAGE sample buffer, 
and then subjected to SDS-PAGE, followed by Western blotting. After blocking with PBS 
containing 5% BSA, the membranes were treated with mouse anti-prohibitin-1 (Neo Markers, 
clone II-14-10), rabbit anti-prohibitin-1 (ABGENT), rabbit anti-prohibitin-2 (BETHYL), and 
mouse anti-ß-actin (SIGMA) antibodies, followed by incubation with HRP-conjugated 
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anti-rabbit IgG antibody or HRP-conjugated anti-mouse IgG antibody (Invitrogen). The bands 
were visualized using an ECL system (GE Healthcare), and their intensities were determined 
with Image J software. 
 
Immunocytochemical staining of Jurkat cells 
Jurkat cells (5 x 105 cells) were treated with 5 µg/ml mouse anti-human CD3 antibody 
(Millipore, clone UCHT1) plus 2.5 µg/ml rabbit anti-prohibitin-1 antibody (ABGENT) or rabbit 
anti-prohibitin-2 antibody (BETHYL) at 4! for 1 h. After washing with PBS, the cells were 
stained with Alexa Fluor 488-conjugated anti-mouse IgG antibody (Molecular Probes), and 
Alexa Fluor 594-conjugated anti-rabbit IgG antibody (Molecular Probes). After fixing with 4% 
paraformaldehyde, nuclei were stained with DAPI, and then the cells were mounted using 
Prolong Gold Antifade Reagent (Invitrogen). 
 
Stimulation of Jurkat cells with anti-CD3 antibody-bound protein A magnetic beads and 
analysis of ERK phosphorylation 
Jurkat cells were treated by the following three methods. (1) Prohibitins and CD3 were 
co-cross-linked using protein A magnetic beads conjugated with mouse anti-human CD3 
antibody and rabbit anti-prohibitin-1 or rabbit anti-prohibitin-2 antibody. (2) Prohibitins and 
CD3 were separately cross-linked using protein A magnetic beads conjugated with anti-CD3 
antibody and anti-prohibitin-1 or anti-prohibitin-2 antibody independently. (3) Jurkat cells were 
stimulated with protein A magnetic beads conjugated with anti-CD3 antibody in the presence of 
soluble anti-prohibitin-1 or anti-prohibitin-2 antibody. A control experiment was performed 
using isotype rabbit IgG instead of anti-prohibitin-1 or -2 antibody. IgG-bound protein A 
magnetic beads, the amount of which was arranged to bind 9 µg of IgG, were added to a 
suspension of Jurkat cells (5 x 104 cells). After incubation at 37! for 10 min, the cells were 
collected, dissolved in SDS-PAGE sample buffer, and then subjected to SDS-PAGE, followed 
by Western blotting. After blocking with PBS containing 5% BSA, the membranes were treated 
with mouse anti-phosphorylated ERK1/2 antibody and rabbit anti-ERK1/2 antibody (CST), 
followed by treatment with HRP-conjugated anti-mouse IgG antibody or HRP-conjugated 
anti-rabbit IgG antibody (Invitrogen). The bands were visualized and their intensities were 
determined as described above.  
 
Statistical analysis 
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Student’s t test was used to determine the significance of differences between sample means. 
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Results and discussion  
Elevated expression of prohibitin-1 and -2 on the surface of activated T cells 
Mouse T cells were prepared from mouse spleens, and stimulated with PMA and ionomycin as 
described under Materials and methods. Activated mouse T cells obtained at 48 h after 
stimulation with PMA and ionomycin were stained with trypan blue, dead cells being estimated 
to comprise less than 5% of the total cells (data not shown). At 0, 24, 48, and 72 h after 
stimulation, some activated and non-activated cells were lysed and the lysates was directly 
subjected to SDS-PAGE, followed by Western blotting. Prohibitins were detected and their 
levels were compared. Total prohibitin-1 and -2 of mouse T cells were increased about 2- and 
2.5-fold, respectively, at 48 h after stimulation with PMA and ionomycin (Fig. 1A). Other 
activated and non-activated cells were treated with biotin to label the cell surface proteins. After 
lysis, biotin-labeled proteins were precipitated with streptavidin-Sepharose. The precipitate was 
subjected to SDS-PAGE, followed by Western blotting and detection with anti-prohibitin-1 and 
-2 antibodies. It should be noted that although cell surface prohibitin-1 and -2 were hardly 
detected in naive T cells, they were remarkably elevated and peaked at 48 h after stimulation. 
Prohibitin-1 and -2 on the cell surface were increased about 66- and 28-fold, respectively (Fig. 
1A). To confirm that biotin-labeled prohibitins were not derived from intracellular membranes 
and cytosol, contamination by other subcellular proteins in the biotin-labeled protein fraction 
was examined. As shown in Supplementary Fig. S1, negligible levels of intracellular proteins 
such as ß-actin, lamin B, and voltage-dependent anion channel (VDAC), which are present in 
the cytosol, nuclei, and mitochondria, respectively, were detected. These data corresponded to 
the level of dead cells estimated by trypan blue-staining, suggesting that these intracellular 
proteins were artificially labeled with biotin due to damaged plasma membrane of dead cells. 
About 20% and 29% of prohibitin-1 and -2, respectively, were detected in the biotin-labeled 
protein fraction, indicating that a considerable proportion of induced prohibitins were expressed 
on the cell surface. 
To see if this induction of prohibitin-1 and -2 in activated T cells is restricted to distinct 
subpopulations of T cells, we separated CD4+ and CD8+ T cells, and then similar experiments 
were performed. As shown in Fig. 1B, marked induction of prohibitins on the cell surface was 
observed irrespective of whether the cells were CD4+ or CD8+ ones, indicating that prohibitins 
were commonly induced in T cells. Since non-physiological stimulation with PMA and 
ionomycin may mimic antigen receptor stimulation, we also tried to stimulate T cells with 
anti-CD3 and anti-CD28 antibodies. As shown in Fig. 1C, prohibitins were also induced and 
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cell surface expression of prohibitins was elevated similarly.  
Human T cells were obtained from PBMCs and stimulated similarly. Human prohibitin-1 and -2 
were also increased about 5.4- and 2.7-fold, respectively, at 48 h after stimulation. Prohibitin-1 
and -2 on the surface of human activated T cells were also elevated 16- and 23-fold, 
respectively (Fig. 2). However, unlike in the case of mouse T cells, prohibitin-2 was induced 
more prominently than prohibitin-1 on the cell surface. This different level of induction cannot 
be explained at present. Elucidation of the induction mechanism may be necessary to clarify this. 
Such a study is currently under investigation. Ross et al. reported that prohibitin-1 and -2 are 
up-regulated upon activation of primary human T cells, and that induced prohibitins are located 
in the mitochondrial inner membrane. Prohibitin-1 and -2 expressed on the surface of mouse T 
cells at 48 h after stimulation were roughly estimated to comprise 20% and 29% of total 
prohibitin-1 and -2, respectively, as described above. This estimation means that residual 
intracellular prohibitins were also elevated by stimulation, and that they may be mainly 
localized to mitochondria, this being consistent with the results reported by Ross et al. 
Expression of prohibitin-1 and -2 on the cell surface has been demonstrated in B lymphocytes 
[11], intestinal epithelial cells [16], and adipose endothelial cells [17]. It appears likely that the 
subcellular localization of prohibitins is cell type-dependent. Notably, we have found that the 
subcellular distribution of prohibitins in T cells was changed with the cellular physiological 
conditions, suggesting their significant biological role. At present, it is uncertain whether 
prohibitins induced on the cell surface are directly incorporated into the plasma membrane after 
their synthesis or translocated from an intracellular compartment such as mitochondria. It has 
been suggested that prohibitin-1 may be able to be translocated between the mitochondria and 
the plasma membrane [3, 17]. In addition, we also compared cell surface prohibitins with 
intracellular ones with respect to their apparent molecular size. Biotin-labeled cell surface 
prohibitins and biotin-unlabeled intracellular ones were applied to gel filtration on Sephadex 
G-75. Both prohibitin-1 and -2, irrespective of whether they were cell surface and intracellular 
ones, showed similar elution patterns and were mostly eluted in the excluded fractions as shown 
in Supplementary Fig. S2, suggesting that cell surface prohibitins also form multi- and 
hetero-complexes.  
 
Cell surface prohibitins on T cell leukemia cells 
Cell surface proteins on T cell leukemia cell lines, Jurkat, Molt-3, and Molt-4 cells, were 
labeled with biotin. Biotin-labeled proteins were prepared and prohibitins were detected as 
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described above. All the cells examined expressed prohibitin-1 and -2 on the cell surface as 
shown in Fig. 3A. Jurkat cells were immunochemically stained with anti-prohibitin-1 and -2 
antibodies, and anti-CD3 antibody. Prohibitin-1 and -2 were immunochemically detected on the 
cell surface, as shown in Fig. 3B. It should be noted that their distribution was not uniform, but 
patchy on the cell surface, and that prohibitin-1 and -2 were completely co-localized with CD3, 
suggesting that prohibitins are located in the rafts including CD3-T cell receptor complexes. 
Lipid rafts are known to be the sites in the plasma membrane where many cellular signaling 
events are initiated. Thus, cell surface prohibitins in activated T cells and T cell leukemia cells 
may function as signaling components. 
 
Inhibition of ERK signaling by anti-prohibitin-1 and -2 antibodies in Jurkat cells 
Jurkat cells were stimulated for 10 min with anti-CD3 antibody in three different combinations 
with anti-prohibitin-1 or -2 antibody, and the cell lysates were subjected to SDS-PAGE, 
followed by Western blotting. Phosphorylated ERK1/2 and total ERK1/2 were detected on 
PVDF membrane. When prohibitins and CD3 on the cell surface of Jurkat cells were 
co-cross-linked using protein A magnetic beads conjugated with anti-CD3 antibody and 
anti-prohibitin-1 or anti-prohibitin-2 antibody, anti-prohibitin-1 antibody inhibited about 40% of 
the phosphorylation of ERK1/2, and anti-prohibitin-2 about 20% and 30% of the 
phosphorylation of ERK1 and ERK2, respectively, suggesting that prohibitin-1 and -2 may be 
involved in the ERK cascade that is brought about by T cell activation (Fig. 4). This effect of 
anti-prohibitin-1 and -2 antibodies on the ERK phosphorylation decreased until 30 min after 
stimulation (data not shown). When Jurkat cells were treated with protein A magnetic beads 
conjugated with anti-CD3 antibody and anti-prohibitin-1 or -2 antibody separately, 
anti-prohibitin-1 and -2 antibodies slightly decreased the phosphorylation of ERK1/2 (data not 
shown). Furthermore, Jurkat cells were treated with protein A magnetic beads conjugated with 
anti-CD3 antibody in the presence of soluble anti-prohibitin-1 or -2 antibody. In this case, an 
effect of anti-prohibitin-1 or -2 antibody was hardly detected (data not shown). These results 
indicate that prohibitins inhibit T cell receptor signaling only when they are co-cross-linked 
with CD3 like programmed death-1 (PD-1) [18]. These results are consistent with the report that 
the Vi polysaccharide of Salmonella typhi can interact with prohibitins on the surface of 
intestinal epithelial cells and down-modulate the MAP kinase cascade, leading to inhibition of 
inflammatory responses [16]. Rajalingam et al. reported that prohibitin-1 is required for 
Ras-mediated Raf activation, which occurs in association with the plasma membrane, and 
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proposed that prohibitin might play a role in the plasma membrane scaffold that ensures the 
Ras-Raf interaction [12]. Thus, these facts suggest a crucial role of prohibitin-1 on the cell 
surface. In addition, cell surface prohibitins may be a direct target for modulating these cellular 
functions. Cytotoxic T lymphocyte antigen-4 (CTLA-4) and PD-1 are known to be induced on 
the surface of activated T cells like prohibitins [19-22]. They are T cell-costimulation receptors 
and critical negative regulators of T cell activation. Antibodies against CTLA-4 and PD-1 have 
been examined as to therapies for inflammatory diseases and cancer [23, 24]. Although the 
precise roles of cell surface prohibitins in T cell receptor-mediated signaling remain to be 
elucidated, prohibitins may also be therapeutic targets for the regulation of T cell activation. 
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Figure legends 
 
Fig. 1. Expression of prohibitin-1 and -2 on the surface of mouse activated T cells.  
 
(A) Mouse T cells were prepared from spleens as described under Materials and methods. T 
cells were stimulated with PMA and ionomycin, and cells were recovered at 0, 24, 48, and 72 
hours after stimulation. Some cells were treated with biotin, and cell surface proteins were 
prepared using streptavidin-Sepharose as described under Materials and methods. Whole cell 
lysates and cell surface proteins were subjected to SDS-PAGE, followed by Western blotting 
and detection of prohibitin-1 (PHB1), prohibitin-2 (PHB2), and ß-actin. Histograms show the 
relative intensities of the prohibitin-1 (closed bars) and -2 (opened bars) bands (averages of 
duplicate experiments), in which each density was normalized as to ß-actin and the value for T 
cells at 0 time was taken as 1. (B) Mouse CD4+ and CD8+ T cells were separated as described 
under Material and methods. These cells were stimulated with PMA and ionomycin, recovered 
at 48 h after stimulation, and then prohibitins were detected as in A. (C) Mouse T cells were 
stimulated with anti-CD3 and anti-CD28 antibodies, and a similar experiment to that in B was 
performed.  
 
Fig. 2. Expression of prohibitin-1 and -2 on the surface of human activated T cells. 
 
Human T cells were prepared from PBMCs and stimulated as described in Fig. 1A. (A) Total 
and cell surface prohibitins were detected as described under Materials and methods. 
Representative data for four experiments are shown. (B) The levels of prohibitin-1 (closed bars) 
and -2 (opened bars) were compared as the relative intensities of bands as described in Fig. 1A. 
Data are expressed as means ± SD (n=4, *p<0.05). 
 
Fig. 3. Expression of prohibitin-1 and -2 on the surface of T cell leukemia cells.  
 
(A) Cell surface prohibitins on Molt-3, Molt-4, and Jurkat cells were analyzed as described in 
Fig. 1A. (B) Jurkat cells were treated with 5 µg/ml anti-CD3 antibody plus 2.5 µg/ml 
anti-prohibitin-1 or -2 antibody, and then with each secondary antibody, followed by fixation 
and staining of nuclei with 4% paraformaldehyde and DAPI, respectively. A control experiment 
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was performed using isotype mouse IgG and rabbit IgG. After mounting, the samples were 
observed by confocal microscopy.  
 
Fig. 4. Effects of anti-prohibitin-1 and -2 antibodies on T cell receptor-mediated signaling.  
 
(A) Jurkat cells (5 x 104 cells) were treated with anti-CD3 antibody plus anti-prohibitin-1 or -2 
antibody-bound protein A magnetic beads at 37! for 10 min. The cells were dissolved in 
SDS-PAGE sample buffer, and subjected to SDS-PAGE, followed by Western blotting and 
detection with anti-phosphorylated ERK1/2 and anti-ERK1/2 antibodies as described under 
Materials and methods. A control experiment was performed using isotype rabbit IgG instead of 
anti-prohibitin-1 and -2 antibodies. Representative data for four experiments are shown. (B) The 
histogram shows the relative intensities of the phosphorylated ERK1 (closed bars) and 
phosphorylated ERK2 (opened bars) bands, in which each density was normalized as to ß-actin 
and the value for control experiment was taken as 1. Data are expressed as means ± SD (n=4, 
*p<0.05) 
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Fig. 4. Effects of anti-prohibitin-1 and -2 antibodies on T cell receptor-mediated 
signaling. 
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Supplementary Materials and methods 
Detection of ß-actin, lamin B, and voltage-dependent anion channel (VDAC).  
Biotin-labeling of activated mouse T cells, preparation of total cell lysates and biotin-labeled 
proteins, SDS-PAGE, and Western blotting were performed as described under Material and 
methods. ß-Actin, lamin B, and VDAC were detected on the PVDF membrane using the 
respective antibodies (Santa cruz, SIGMA, and CST, respectively). Prohibitin-1 and -2 were 
also detected as described under Material and methods. 
 
Gel filtration of prohibitins on Sephadex G-75. 
Activated mouse T cell lysates containing cell surface proteins labeled with biotin were 
prepared as described under Materials and methods, and then applied to Sephadex G-75 (1 x 42 
cm, GE Healthcare). Proteins were eluted with 50 mM Tris-HCl, pH7.5, 150 mM NaCl, 1% 
Triton-X100, and 2mM EDTA, and fractions of 0.65 ml were collected (80 fractions). An 
aliquot was dot-blotted onto the Zeta-Probe Membrane (BIO-RAD) to detect biotin-labeled 
proteins. Streptavidin-Sepharose was added to another aliquot of each fraction, and 
biotin-labeled and -unlabeled proteins were separated. Both proteins were subjected to 
SDS-PAGE, followed by Western blotting and detection of prohibitins. The bands were 
visualized using an ECL system (GE Healthcare), and their intensities were determined with 
Image J software. 
Supplementary Figure legends 
 
Fig. S1. Detection of ß-actin, lamin B, VDAC, and prohibitin-1 and -2 recovered in the 
biotin-labeled protein fraction and in total cell lysates. 
 
Biotin-labeled proteins and total cell lysates were subjected to SDS-PAGE, followed by 
Western blotting. ß-Actin, lamin B, VDAC, and prohibitin-1 and -2 were detected using the 
respective antibodies.  
 
Fig. S2. Elution pattern of cell surface and intracellular prohibitins.  
 
Activated mouse T cell lysates containing cell surface proteins labeled with biotin were applied 
to Sephadex G-75, and eluted with 50 mM Tris-HCl, pH7.5, 150 mM NaCl, 1% Triton-X100, 
and 2mM EDTA. Fractions of 0.65 ml were collected. (A) An aliquot was directly dot-blotted 
onto the Zeta-Probe Membrane and biotin-labeled proteins were detected. 
Streptavidin-Sepharose was added to another aliquot, and biotin-labeled and -unlabeled proteins 
were separated. Both proteins were subjected to SDS-PAGE, followed by Western blotting, 
respectively. Prohibitins were detected in the both biotin-labeled and -unlabeled proteins using 
anti-prohibitin-1 and -2 antibodies. (B) Elution profile based on the relative densities of 
biotin-labeled total proteins (closed squares), prohibitin-1 (closed circles), and prohibitin-2 
(opened circles), is shown. The arrowheads A, B, and C, represent the elution positions of blue 
dextran 2000 (2000 kDa), conalbumin (75 kDa), and carbonic anhydrase (29 kDa), respectively. 
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